Japan to Share GMP Inspection Findings on API Makers

Japan’s Pharmaceutical and Medical Devices Agency is joining the ranks of the FDA, the EMA and a few other drug regulators by agreeing to participate in a program that allows the agencies to share GMP inspection plans and results for API manufacturing sites.
Source: International Pharmaceutical Regulatory Monitor